Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zenas BioPharma (ZBIO) FCF Margin (2024 - 2025)

Zenas BioPharma has reported FCF Margin over the past 2 years, most recently at 370.69% for Q1 2025.

  • Quarterly results put FCF Margin at 370.69% for Q1 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was 1723.51% (up 67259.0% YoY), and the annual figure for FY2025 was 1723.51%, up 67259.0%.
  • FCF Margin for Q1 2025 was 370.69% at Zenas BioPharma, up from 772.56% in the prior quarter.
  • Over the last five years, FCF Margin for ZBIO hit a ceiling of 370.69% in Q1 2025 and a floor of 772.56% in Q4 2024.